Ambet, Alwina A.

HRN: 25-09-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2024
CO-AMOXICLAV 625MG (TAB)
05/27/2024
06/03/2024
PO
625mg
BID X 7 Days
S/P NSVD
Waiting Final Action 
05/27/2024
CEFUROXIME 1.5GM (VIAL)
05/27/2024
05/28/2024
IV
1.5gm
Q8 3 Doses
Uti
Waiting Final Action 
05/27/2024
CEFUROXIME 500MG (TAB)
05/27/2024
06/02/2024
PO
500mg
BID
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: